| Financial Year |
March 31 2022 |
| Monetary Funds |
586,051,360.78 |
| Held-for-trading Financial Assets |
324,657,680.56 |
| Notes Receivable |
128,023,855.08 |
| Accounts Receivable |
310,806,510.67 |
| Advances to Suppliers |
3,176,477.38 |
| Other Receivables |
2,153,761.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
317,720,168.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
121,732,790.81 |
| Total Current Assets |
1,839,910,729.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
134,710,034.02 |
| Under-construction Projects |
403,085,990.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,546,702.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,002,640.78 |
| Other Non-Current Assets |
25,170,965.44 |
| Sub-Total of Non-Current Assets |
612,516,333.79 |
| Total Assets |
2,452,427,063.43 |
| Short-Term Loans |
127,990,778.51 |
| Trading Financial liabilities |
1,569,737.03 |
| Notes Payable |
361,048,802.19 |
| Accounts Payable |
427,578,025.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,572,701.42 |
| Taxes Payable |
12,301,287.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,978,916.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
354,063.96 |
| Sub-Total of Current Liabilities |
958,973,460.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,170,546.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,267,796.24 |
| Total Liabilities |
988,241,256.85 |
| Paid-In Capital(Or Share Stock) |
142,923,950.00 |
| Capital Surplus |
781,155,434.10 |
| Surplus Reserve |
18,607,751.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
519,618,981.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,464,185,806.58 |
| Owner's Equity（Stockholder's Equity） |
1,464,185,806.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,452,427,063.43 |
